Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

dexmedetomidine

dexmedetomidine
Brand names: Igalmi, Precedex
Form Strength
FILM, SUBLINGUAL 120 mcg; 180 mcg
SOLUTION, INTRAVENOUS 4 mcg/mL-NaCl 0.9%; 100 mcg/mL


Additional Information:

Use in a ventilated Critical Care patient: See 901.5008

Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008 \

For pediatric long term sedation weaning: See Protocol 912.6016

Infusion Concentrations and Ranges:

Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)

Igalmi (Sublingual Film):

  • Formulary, Restricted
    1. Treatment of agitation in adult patients with schizophrenia or bipolar disorder
    2. Prescribing by psychiatry, at Unity*
    3. Past failure or intolerance to both antipsychotics and benzodiazepines, or current contraindication to both

     * Implementation of dexmedetomidine sublingual (Igalmi) at Unity is pending.

 


Last updated: Oct. 9, 2023







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.